SecBot SecBot

NVNO

enVVeno Medical Corp
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001661053 Healthcare & Medical Devices
$6.74 +0.03 (+0.45%)
Oct 27 4:00 PM ET · prev $6.71
Market cap
$4.6M
Nano cap
Median target
$30.00
+345% · range $30.00–30.00
1 year
−73.0%
from $24.99 · Oct 28
30 days
−23.5%
from $8.81
52-week range
$6.65–25.17
−73% from high · low Oct 23
Avg volume 20D
43.6K
Oct 12 spike 122.9K
Short interest
11.8K
≈1.7% of shares · −12.9%
Days to cover
1.0
at average volume
Insider net
−$1.7K
0 buyers · 1 seller · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
2
analyzed by SecBot
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score
Strongest NEUTRAL Analysis based on filing metadata only — document content was unavailable. enVVeno Medical Corp filed an 8-K…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider sold $1.7K.

  • InstitutionsMIXED

    Q2 2026: 0 added (0 new), 2 trimmed or exited.

  • Short sellersSTEADY

    Short interest −12.9% to 11.8K shares. 1.0 days to cover, ≈1.7% of shares.

  • TrendDOWNTREND

    27% below its 50-day average. New closing low $6.65 on Oct 23.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BlackRock, Inc.NEAR_EXIT414$4.4K
UBS Group AGNEAR_EXIT1$11.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

12-month targets · 1 analysts

Price is below the lowest target. Median implies +345%.Targets as of Oct 28, 2026.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 28, 2026
Earnings date
🔒 Fresh data, subscribers only
Sep 16, 2026
Trading halt
Halt Resumed: NVNO — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-16T15:24:00.000Z | Resumed 2026-09-16T15:34:00.000Z
Sep 16, 2026
Trading halt
Trading Halt: NVNO — LUDP (Volatility Trading Pause)
enVVeno Medical Corp Cmn | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Jul 29, 2026
Earnings date
NVNO Q2 2026 Earnings After Market Close — 2026-07-29
Apr 28, 2026
Earnings date
NVNO Q1 2026 Earnings After Market Close — 2026-04-28

Insider ledger

Form 4
$0
bought · 0 insiders
$1.7K
sold · 1 insider
DateInsiderTypeValue
Sep 11, 2026
Duhay Francis
Director
SELL$123.31
Mar 12, 2026
Duhay Francis
Director
SELL$1.6K

Earnings setup

Estimates
−$3.27
EPS estimate, this quarter
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$3.27-$3.27–-$3.27—$0.00
Next Q-$2.35-$2.35–-$2.35—$0.00
Current FY-$16.19-$16.19–-$16.19—$0.00
Next FY-$6.22-$6.22–-$6.22—$0.00

Short side

FINRA· Oct 15, 2026
11,771
shares short
-12.9%
vs prior settlement
1.0
days to cover
≈1.7%
of shares outstanding
Trading halts
Sep 16, 2026Volatility PauseResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 28, 2026 Earnings calendar
🔒 Fresh data, subscribers only
Sep 11, 2026 Insider
Duhay Francis sold 11 shares
Director @ $11.21 ($123.31)
Jul 14, 2026 SEC
Analysis based on filing metadata only — document content was unavailable. enVVeno Medical Corp filed an 8-K on July…
8-K — Impact 2/10
Jun 30, 2026 Inst.
BlackRock, Inc. — NEAR_EXIT
414 shares ($4.4K)
Jun 30, 2026 Inst.
UBS Group AG — NEAR_EXIT
1 shares ($11.00)
Apr 29, 2026 SEC
enVVeno Medical received FDA IDE approval to commence the TAVVE pivotal study of its enVVe non-surgical replacement…
8-K — Impact 6/10
Mar 12, 2026 Insider
Duhay Francis sold 140 shares
Director @ $11.52 ($1.6K)

SecBot reports

2 filings · 1 bullish · 0 bearish · 1 neutral
All NVNO filing & press-release reports (2)